LAMP1 and neoplasm: Furthermore, the frequency of T cell effector markers CD107a was higher in the tumor PDO group (CD107a: 9%) than those from the normal PDO and PDO alone group (CD107a: 4.4%, 1.8%: respectively) (Fig. 3E, F, Supplementary Fig. S3).